Wenda Greer

2.3k total citations
57 papers, 1.3k citations indexed

About

Wenda Greer is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Wenda Greer has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 11 papers in Hematology. Recurrent topics in Wenda Greer's work include Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Wenda Greer is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Wenda Greer collaborates with scholars based in Canada, United States and France. Wenda Greer's co-authors include Joseph Kaplan, Noreen M. Walsh, Laurence A. Rubin, Katherine Siminovitch, Monica Peacocke, Dan Fontaine, Nisa Renault, Randall A. Heidenreich, Pak C. Kwong and Barbara Karten and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Wenda Greer

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenda Greer Canada 23 503 401 279 249 157 57 1.3k
Alan G. Rosmarin United States 23 985 2.0× 332 0.8× 172 0.6× 414 1.7× 262 1.7× 47 1.7k
James O. Price United States 23 895 1.8× 453 1.1× 170 0.6× 324 1.3× 248 1.6× 49 2.1k
Gerald Horan United States 17 1.1k 2.1× 269 0.7× 338 1.2× 329 1.3× 73 0.5× 25 2.1k
Otto Sánchez Canada 22 1.3k 2.7× 909 2.3× 354 1.3× 197 0.8× 182 1.2× 41 2.5k
Christophe F. Grosset France 22 930 1.8× 218 0.5× 135 0.5× 385 1.5× 246 1.6× 53 1.9k
Tauro Maria Neri Italy 21 591 1.2× 609 1.5× 332 1.2× 496 2.0× 114 0.7× 51 2.2k
Kenichi Harigaya Japan 28 1.3k 2.5× 567 1.4× 181 0.6× 582 2.3× 259 1.6× 93 2.6k
Masayoshi Minegishi Japan 19 417 0.8× 270 0.7× 147 0.5× 461 1.9× 364 2.3× 85 1.3k
Arthur H. Tatum United States 24 433 0.9× 448 1.1× 87 0.3× 298 1.2× 107 0.7× 50 1.7k
P Laurila Finland 20 613 1.2× 266 0.7× 154 0.6× 284 1.1× 132 0.8× 37 1.7k

Countries citing papers authored by Wenda Greer

Since Specialization
Citations

This map shows the geographic impact of Wenda Greer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenda Greer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenda Greer more than expected).

Fields of papers citing papers by Wenda Greer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenda Greer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenda Greer. The network helps show where Wenda Greer may publish in the future.

Co-authorship network of co-authors of Wenda Greer

This figure shows the co-authorship network connecting the top 25 collaborators of Wenda Greer. A scholar is included among the top collaborators of Wenda Greer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenda Greer. Wenda Greer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marignani, Paola A., et al.. (2018). P3.13-31 Creating a Precision Medicine Pipeline for Lung Cancers.. Journal of Thoracic Oncology. 13(10). S989–S989.
2.
Carter, Michael D., Daniel Gaston, Weei‐Yuarn Huang, et al.. (2017). Genetic profiles of different subsets of Merkel cell carcinoma show links between combined and pure MCPyV-negative tumors. Human Pathology. 71. 117–125. 53 indexed citations
3.
Quirós, Yara Bernaldo de, David S. Rotstein, Andrea Bogomolni, et al.. (2017). Discrimination between bycatch and other causes of cetacean and pinniped stranding. Diseases of Aquatic Organisms. 127(2). 83–95. 33 indexed citations
4.
Riddell, D. Christie, et al.. (2010). Multiplex Ligation-Dependent Probe Amplification Versus Multiprobe Fluorescence in Situ Hybridization To Detect Genomic Aberrations in Chronic Lymphocytic Leukemia. Journal of Molecular Diagnostics. 12(2). 197–203. 26 indexed citations
5.
Neumann, Paul E., et al.. (2008). Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations. Leukemia. 22(8). 1551–1556. 5 indexed citations
6.
Dyack, Sarah, et al.. (2007). An autosomal recessive form of Alagille-like syndrome that is not linked to JAG1. Genetics in Medicine. 9(8). 544–550. 5 indexed citations
7.
Renault, Nisa, Sarah Dyack, Melanie J. Dobson, et al.. (2007). Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. European Journal of Human Genetics. 15(6). 628–637. 61 indexed citations
8.
Foote, Clary J., Wenda Greer, Bryce Kiberd, et al.. (2007). Polymorphisms of Multidrug Resistance Gene (MDR1) and Cyclosporine Absorption in De Novo Renal Transplant Patients. Transplantation. 83(10). 1380–1384. 20 indexed citations
9.
Foote, Clary J., Wenda Greer, B. Kiberd, et al.. (2006). MDR1 C3435T Polymorphisms Correlate With Cyclosporine Levels in De Novo Renal Recipients. Transplantation Proceedings. 38(9). 2847–2849. 22 indexed citations
10.
Williams, Geoffrey S., et al.. (2005). Intravascular T-cell lymphoma with bowel involvement: Case report and literature review. American Journal of Hematology. 78(3). 207–211. 17 indexed citations
11.
Greer, Wenda, et al.. (2003). Case of acute lymphoblastic leukemia presenting with t(14;18)/BCL2, t(8;14)/cMYC, and t(1;2)/FCGR2B. American Journal of Hematology. 74(2). 112–118. 10 indexed citations
12.
Greer, Wenda, et al.. (2000). Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.. PubMed. 23(6). 366–75. 3 indexed citations
13.
Mandla, S, et al.. (2000). Familial myelodysplastic syndrome with early age of onset. American Journal of Hematology. 64(1). 53–58. 3 indexed citations
14.
Goobie, Sharan, et al.. (1998). Genetic Analysis of Familial Myelodysplastic Syndrome. Cancer Genetics and Cytogenetics. 105(2). 113–118. 9 indexed citations
15.
16.
Nevill, Thomas J., M. J. Barnett, Katherine Robinson, Wenda Greer, & G. L. Phillips. (1992). RETURN TO DURABLE DONOR HAEMATOPOIESIS AFTER BLAST PHASE RELAPSE OF CHRONIC MYELOID LEUKAEMIA FOLLOWING MARROW TRANSPLANTATION. British Journal of Haematology. 80(2). 256–258. 3 indexed citations
17.
Clarke, Joe T.R., et al.. (1991). Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.. PubMed. 49(2). 289–97. 39 indexed citations
18.
Greer, Wenda, et al.. (1990). Linkage relationships of the Wiskott-Aldrich syndrome to 10 loci in the pericentromeric region of the human X chromosome. Genomics. 6(3). 568–571. 27 indexed citations
19.
Greer, Wenda, Elizabeth Higgins, D. Robert Sutherland, et al.. (1989). Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochemistry and Cell Biology. 67(9). 503–509. 40 indexed citations
20.
Prasad, Kailash, Wenda Greer, Alberto Severini, & Joseph Kaplan. (1987). Increase in intracellular Na+: transmembrane signal for rejoining of DNA strand breaks in proliferating lymphocytes.. PubMed. 47(20). 5397–400. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026